Ingenza Advances inABLE® Biomanufacturing Technologies in Collaboration with Syngenta
News Oct 18, 2017
Ingenza has reached a major technical milestone with Syngenta in their collaboration to develop efficient manufacturing technologies for innovative crop protection products.
Ingenza’s leadership in industrial biotechnology and synthetic biology has been validated by this application of key microbial gene maintenance and expression technologies which will now be further developed by Syngenta. The collaboration capitalises on Ingenza’s proprietary inABLE suite of capabilities in gene expression, microbial strain improvement and bioprocess scale up.
Dr. Ian Fotheringham, Managing Director at Ingenza said “We are delighted by the results of our collaboration with Syngenta. Ingenza’s innovative technologies add significant value to further support Syngenta’s leading position in agricultural biotechnology. Ingenza looks forward to establishing an exceptional partnership with Syngenta, working together to enhance global agriculture and food security.”
Dr. Paul Oeller, Head of Technology Acquisition at Syngenta said “There are significant challenges associated with finding new technologies to feed the world’s population and we are always looking to work with external technology providers to achieve these goals. It has been a pleasure working with the Ingenza team. The collaborative and innovative culture shared between the Ingenza and Syngenta teams has made this collaboration a success. We are excited about the next phase of work to further evaluate the technology.”
New Portable Malaria Screening Instrument DevelopedNews
A new prototype for a portable instrument capable of early-stage malaria detection has been developed by a team of researchers at the USC Viterbi School of Engineering.READ MORE
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Antitumor Immune Function in Liver Controlled by Gut MicrobiomeNews
Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. The study showed that bacteria found in the gut of mice affect the liver’s antitumor immune function. The findings have implications for understanding the mechanisms that lead to liver cancer and for therapeutic approaches to treat them.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018